Can excess thyroid hormone increase adrenergic sensitivity and cause palpitations, tremor, heat intolerance, anxiety, and sleep disturbance?

Excess thyroid hormone—whether from endogenous thyrotoxicosis or levothyroxine over-replacement—has a well-established clinical symptom pattern. The symptoms in the claim are strongly supported; the broad explanation that all result from generalized adrenergic hypersensitivity is more tentative.

Clinical evidence

• Palpitations/tachycardia, fine tremor, heat intolerance, anxiety or nervousness, and insomnia/sleep disturbance are recognized manifestations of thyroid-hormone excess in clinical reviews, thyrotoxicosis guidance, and FDA levothyroxine labeling.
• Increased sweating commonly accompanies heat intolerance and is also described with therapeutic thyroid-hormone overdosage.
• These symptoms are clinically important but nonspecific. In a 64-year-old receiving thyroid replacement, they warrant biochemical assessment for excess hormone exposure rather than thyroid-dose adjustment based on symptoms alone; TSH is particularly informative.

Mechanistic interpretation

• Thyroid hormone may enhance adrenergic signaling in selected tissues. Human studies report increased β-adrenergic receptor density in adipose tissue and skeletal muscle after T3 exposure; adipocytes from thyrotoxic patients showed increased β2-receptor numbers and β2-mediated lipolysis.
• Experimental cardiac data support possible post-receptor amplification: a cardiac thyrotoxicosis mouse model had greater agonist- and forskolin-stimulated cAMP generation, apparently involving reduced inhibitory Gi/Go signaling.
• However, controlled human studies did not consistently show stronger epinephrine-induced metabolic or hemodynamic responses, and a thyrotoxic baboon model did not show increased β-agonist responsiveness. Thus, tissue-specific adrenergic amplification is plausible, but generalized human catecholamine hypersensitivity is not established.

Safety implications

• Sustained thyroid-hormone excess and suppressed TSH are associated with atrial fibrillation and osteoporosis. ATA guidance cites a threefold higher 10-year atrial-fibrillation risk in adults over 65 with TSH <0.1 mIU/L, largely among levothyroxine users.

Bottom line

• Excess thyroid hormone can credibly cause every listed symptom. Adrenergic sensitization is a biologically plausible, tissue-dependent contributor—not a universally proven explanation—and persistent symptoms or suppressed TSH merit prompt clinical review.